HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question!
Michele PellegrinoFrancesca GiordanoFrancesca De AmicisMaria MarraPaola TucciStefania MarsicoStefano AquaroPublished in: Current issues in molecular biology (2024)
The biological activity of structural HIV-1 proteins is not limited to ensuring a productive viral infection but also interferes with cellular homeostasis through intra- and extracellular signaling activation. This interference induces genomic instability, increases the lifespan of the infected cell by inhibiting apoptosis, and subverts cell senescence, resulting in unrestricted cell proliferation. HIV structural proteins are present in a soluble form in the lymphoid tissues and blood of infected individuals, even without active viral replication. The HIV matrix protein p17, the envelope glycoprotein gp120, the transenvelope protein gp41, and the capsid protein p24 interact with immune cells and deregulate the biological activity of the immune system. The biological activity of HIV structural proteins is also demonstrated in endothelial cells and some tumor cell lines, confirming the ability of viral proteins to promote cell proliferation and cancer progression, even in the absence of active viral replication. This review corroborates the hypothesis that HIV structural proteins, by interacting with different cell types, contribute to creating a microenvironment that is favorable to the evolution of cancerous pathologies not classically related to AIDS.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- cell proliferation
- men who have sex with men
- single cell
- endothelial cells
- cell therapy
- sars cov
- stem cells
- gene expression
- squamous cell carcinoma
- oxidative stress
- protein protein
- dna damage
- cell death
- dna methylation
- mesenchymal stem cells
- signaling pathway
- young adults
- bone marrow
- protein kinase
- genome wide